| Synonyms: | |
| Status: | Approved (2021) |
| Entry Type: | Unknown |
| Molecule Category: | UNKNOWN |
| UNII: | AD4J2O47FQ |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Glucagon receptor agonist | FDA |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hypoglycemia | 3 | D007003 | ClinicalTrials |
| Congenital Hyperinsulinism | 3 | D044903 | ClinicalTrials |
| Diabetes Mellitus, Type 1 | 2 | D003922 | ClinicalTrials |
| Nesidioblastosis | 2 | D046768 | ClinicalTrials |
Related Entries
MCS
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1544300-84-6 |
| ChEMBL | CHEMBL4297741 |
| FDA SRS | AD4J2O47FQ |
| PubChem | 126961379 |
CONTENTS